Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
26-10-02	NOK 0.4810	+4.57%	39,956,182
26-10-01	NOK 0.4600	-19.30%	71,625,170
26-09-30	NOK 0.5700	+3.26%	157,229,545
26-09-29	NOK 0.5520	+88.72%	114,287,421
26-09-28	NOK 0.2925	-2.34%	1,750,358

Real-time Oslo Bors

More quotes

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Oslo Bors 10:45:00 2026-10-02 EDT			5-day change	1st Jan Change
0.4810 ^NOK	+4.57%		+60.60%	-85.25%

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-10	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI

Market Cap	196M 20.4M 18.13M 16.9M 15.4M 28.87M 1.96B 29.32M 205M 79.4M 1B 76.58M 74.92M 3.21B	P/E 2026 *	-1.37x	P/E 2027 *	-3.01x
Enterprise Value	187M 19.46M 17.29M 16.13M 14.7M 27.54M 1.87B 27.97M 195M 75.76M 956M 73.07M 71.48M 3.06B	EV / Sales 2026 *	187x	EV / Sales 2027 *	-
Free-Float	71.12%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	LIFE	Real-time
CBOE		Real-time
Nasdaq Stockholm	LIFE O	Delayed
Deutsche Boerse AG	LFC0	Delayed
Boerse Muenchen	LFC0	Real-time
Börse Stuttgart	LFC0	Delayed
CBOE		Real-time

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-10	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
08-31	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
08-19	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-19	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-26	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-18	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE

Lifecare ASA Stock

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news: Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Price Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

09-30	Lifecare : Mandatory Notification of Trade by Primary Insider	PU
09-29	Lifecare successfully manufactures first functional implants in-house in Bergen	AQ
08-19	Lifecare : Interim Report Q2 2026 Presentation	PU
08-19	LIFE: Lifecare ASA Q2 2026 results	PU
08-12	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ

1 day	+4.57%
1 week	+60.60%
Current month	-15.61%
1 month	+65.86%
3 months	+65.86%
6 months	+7.85%
Current year	-85.25%

1 week	0.29	0.84
1 month	0.28	0.84
Current year	0.27	1.99
1 year	0.27	8.02
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	2020-09-06
Petter Nielsen DFI	Director of Finance/CFO	-	2026-03-31
Torsten Ernst PRN	Corporate Officer/Principal	-	2024-02-29

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	2020-06-25
Morten Foros Krohnstad CHM	Chairman	-	2021-05-07
Lutz Heinemann BRD	Director/Board Member	-	2020-11-19

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	+4.57%	+60.60%	-93.13%	-98.99%	20.37M
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.16B
ARGENX SE	-3.11%	-3.53%	+21.92%	+74.60%	57.39B
LONZA GROUP AG	+0.89%	-0.63%	+4.28%	+34.51%	47.64B
REVOLUTION MEDICINES, INC.	+0.36%	+0.81%	+352.17%	+689.61%	44.29B
IQVIA HOLDINGS INC.	-0.96%	-4.50%	+26.36%	+33.18%	42.5B
BEONE MEDICINES AG	-0.20%	-0.77%	+3.74%	+100.60%	40.71B
CELLTRION, INC.	-0.54%	+2.93%	+9.31%	+50.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	-2.68%	+2.92%	+29.63%	+19.50%	28.53B
BIONTECH SE	+0.05%	-1.64%	-7.28%	-14.06%	24.34B
Average	+0.25%	+5.53%	+39.64%	+98.35%	39.06B
Weighted average by Cap.	+0.12%	-0.84%	+58.76%	+129.90%

	2026 *	2027 *
Net sales	1M 104K 92.43K 86.18K 78.54K 147K 10.02M 149K 1.04M 405K 5.11M 391K 382K 16.34M	-
Net income	-109M -11.34M -10.07M -9.39M -8.56M -16.04M -1.09B -16.3M -114M -44.13M -557M -42.57M -41.64M -1.78B	-67M -6.97M -6.19M -5.77M -5.26M -9.86M -671M -10.02M -69.88M -27.13M -342M -26.16M -25.6M -1.1B
Net Debt	-9M -936K -832K -776K -707K -1.32M -90.15M -1.35M -9.39M -3.64M -45.97M -3.51M -3.44M -147M	4M 416K 370K 345K 314K 589K 40.07M 598K 4.17M 1.62M 20.43M 1.56M 1.53M 65.38M